◆
BLACKSPECTER
AI Chat öffnen →
BlackSpecter
›
Aktien
›
ACAD
ACAD
(ACAD)
Kennzahlen
Marktkapitalisierung
n/a
KGV (TTM)
n/a
Umsatz (TTM)
n/a
EBITDA
n/a
Dividendenrendite
n/a
52W Hoch
n/a
52W Tief
n/a
Beta
n/a
EPS (TTM)
n/a
Forward KGV
n/a
PEG Ratio
n/a
Short-Quote
n/a
Analysten-Ratings
Keine Analysten-Daten verfügbar
Earnings
Keine Earnings-Daten verfügbar
Aktuelle News
Motley Fool
·
vor 3 Tagen
An Acadia Pharmaceuticals Insider Sold Nearly Half Their Shares in the Company. What Does That Mean for Investors?
Simply Wall St.
·
vor 4 Tagen
ACADIA Pharmaceuticals (ACAD) Names A New Chief People Officer, Is It Still Below Fair Value?
Simply Wall St.
·
vor 4 Tagen
Is ACADIA Pharmaceuticals (ACAD) Still Undervalued After The Daybue Win?
Simply Wall St.
·
vor 4 Tagen
How CHMP’s Positive Rett Syndrome Ruling on DAYBU Could Impact ACADIA Pharmaceuticals (ACAD) Investors
Zacks
·
vor 5 Tagen
Verastem (VSTM) Surges 6.3%: Is This an Indication of Further Gains?
Zacks
·
vor 5 Tagen
RPRX or ACAD: Which Is the Better Value Stock Right Now?
Frag BlackSpecter AI über ACAD
Earnings-Analyse, Bewertungs-Check, Peer-Vergleich — in Sekunden.
Ist ACAD kaufenswert?
ACAD Earnings Analyse
ACAD Bewertung
AI Chat öffnen →